• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重链抗体的可变片段(VHHs):一种新型的神奇药物分子?

Variable fragments of heavy chain antibodies (VHHs): a new magic bullet molecule of medicine?

作者信息

Smolarek Dorota, Bertrand Olivier, Czerwinski Marcin

机构信息

Laboratory of Glycoconjugate Immunochemistry, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland.

出版信息

Postepy Hig Med Dosw (Online). 2012 Jun 14;66:348-58. doi: 10.5604/17322693.1000334.

DOI:10.5604/17322693.1000334
PMID:22706121
Abstract

Serum of animals belonging to the Camelidae family (camels and llamas) contains fully active antibodies that are naturally devoid of light chains. Variable domains derived from heavy chain antibodies (hcAb) called VHHs or nanobodies™ can bind antigens as effectively as full-length antibodies and are easy to clone and express. Because of their potential, VHHs are being intensively studied as potential therapeutic, diagnostic and imaging tools. The paper reviews the molecular background of heavy chain antibodies and describes methods of obtaining recombinant fragments of heavy chain antibodies as well as their therapeutic, diagnostic and other applications.

摘要

骆驼科动物(骆驼和美洲驼)的血清中含有完全活性的抗体,这些抗体天然不含轻链。源自重链抗体(hcAb)的可变结构域,称为VHH或纳米抗体™,能够像全长抗体一样有效地结合抗原,并且易于克隆和表达。由于其潜力,VHH正作为潜在的治疗、诊断和成像工具被深入研究。本文综述了重链抗体的分子背景,描述了获得重链抗体重组片段的方法及其治疗、诊断和其他应用。

相似文献

1
Variable fragments of heavy chain antibodies (VHHs): a new magic bullet molecule of medicine?重链抗体的可变片段(VHHs):一种新型的神奇药物分子?
Postepy Hig Med Dosw (Online). 2012 Jun 14;66:348-58. doi: 10.5604/17322693.1000334.
2
Nanobodies in therapeutic applications.治疗应用中的纳米抗体。
Curr Opin Mol Ther. 2007 Aug;9(4):327-35.
3
Properties, production, and applications of camelid single-domain antibody fragments.骆驼科单域抗体片段的特性、生产及应用
Appl Microbiol Biotechnol. 2007 Nov;77(1):13-22. doi: 10.1007/s00253-007-1142-2. Epub 2007 Aug 18.
4
Introduction to heavy chain antibodies and derived Nanobodies.重链抗体及衍生纳米抗体简介。
Methods Mol Biol. 2012;911:15-26. doi: 10.1007/978-1-61779-968-6_2.
5
The development of nanobodies for therapeutic applications.用于治疗应用的纳米抗体的研发。
Curr Opin Investig Drugs. 2009 Nov;10(11):1212-24.
6
Nanobodies: From Serendipitous Discovery of Heavy Chain-Only Antibodies in Camelids to a Wide Range of Useful Applications.纳米抗体:从偶然发现骆驼科动物重链抗体到广泛应用
Methods Mol Biol. 2022;2446:3-17. doi: 10.1007/978-1-0716-2075-5_1.
7
Over expression of anti-MUC1 single-domain antibody fragments in the yeast Pichia pastoris.抗MUC1单域抗体片段在毕赤酵母中的过表达。
Mol Immunol. 2006 Feb;43(5):426-35. doi: 10.1016/j.molimm.2005.03.003. Epub 2005 Mar 25.
8
Perspectives for the Development of CD38-Specific Heavy Chain Antibodies as Therapeutics for Multiple Myeloma.CD38 特异性重链抗体作为多发性骨髓瘤治疗药物的研发前景。
Front Immunol. 2018 Nov 6;9:2559. doi: 10.3389/fimmu.2018.02559. eCollection 2018.
9
Application of camelid heavy-chain variable domains (VHHs) in prevention and treatment of bacterial and viral infections.驼科重链可变区(VHH)在预防和治疗细菌及病毒感染中的应用。
Int Rev Immunol. 2018 Jan 2;37(1):69-76. doi: 10.1080/08830185.2017.1397657. Epub 2017 Nov 28.
10
VHH characterization.Recombinant VHHs: Production, characterization and affinity.VHH 表征。重组 VHH:生产、表征和亲和力。
Anal Biochem. 2020 Jan 15;589:113491. doi: 10.1016/j.ab.2019.113491. Epub 2019 Oct 30.

引用本文的文献

1
Evaluation of the Potential Impact of In Silico Humanization on VH Dynamics.评估计算机模拟人源化对 VH 动力学的潜在影响。
Int J Mol Sci. 2023 Sep 26;24(19):14586. doi: 10.3390/ijms241914586.
2
Construction of an alpaca immune antibody library for the selection of nanobodies against proteins.构建用于筛选抗蛋白质纳米抗体的羊驼免疫抗体文库。
Front Bioeng Biotechnol. 2023 Jun 9;11:1207048. doi: 10.3389/fbioe.2023.1207048. eCollection 2023.
3
Development of therapeutic antibodies for the treatment of diseases.用于疾病治疗的治疗性抗体的研发。
Mol Biomed. 2022 Nov 22;3(1):35. doi: 10.1186/s43556-022-00100-4.
4
VH Structural Modelling Approaches: A Critical Review.VH 结构建模方法:批判性评价。
Int J Mol Sci. 2022 Mar 28;23(7):3721. doi: 10.3390/ijms23073721.
5
Noninvasive Immuno-PET Imaging of CD8 T Cell Behavior in Influenza A Virus-Infected Mice.甲型流感病毒感染小鼠中 CD8 T 细胞行为的无创免疫 PET 成像。
Front Immunol. 2021 Nov 3;12:777739. doi: 10.3389/fimmu.2021.777739. eCollection 2021.
6
Nanobodies as , non-invasive, imaging agents.纳米抗体作为非侵入性成像剂。
RSC Chem Biol. 2021 Mar 8;2(3):685-701. doi: 10.1039/d1cb00023c.
7
Perspective on therapeutic and diagnostic potential of camel nanobodies for coronavirus disease-19 (COVID-19).骆驼纳米抗体在冠状病毒病-19(COVID-19)治疗和诊断方面的潜力展望。
3 Biotech. 2021 Feb;11(2):89. doi: 10.1007/s13205-021-02647-5. Epub 2021 Jan 22.
8
A Novel Nanobody Scaffold Optimized for Bacterial Expression and Suitable for the Construction of Ribosome Display Libraries.一种新型纳米抗体支架,经过优化可用于细菌表达,适合核糖体展示文库的构建。
Mol Biotechnol. 2020 Jan;62(1):43-55. doi: 10.1007/s12033-019-00224-z.
9
Targeting Colorectal Cancer Cell Lines Using Nanobodies; AgSK1as a Potential Target.使用纳米抗体靶向结肠癌细胞系;AgSK1作为一个潜在靶点。
Iran J Biotechnol. 2017 Aug 19;15(2):78-86. doi: 10.15171/ijb.1472. eCollection 2017.
10
Nanobody-Antigen Conjugates Elicit HPV-Specific Antitumor Immune Responses.纳米抗体-抗原偶联物诱导 HPV 特异性抗肿瘤免疫应答。
Cancer Immunol Res. 2018 Jul;6(7):870-880. doi: 10.1158/2326-6066.CIR-17-0661. Epub 2018 May 23.